Arbutus Biopharma Corpora... (ABUS)
Arbutus Biopharma Max Pain By Strike
ABUS trades at $3.33, 11.0% above the near-term max pain of $3 expiring Sep 19, 2025 (33 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$4), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Arbutus Biopharma Max Pain By Expiry
Max pain for ABUS shows a downward trend from 4 to 2.5, indicating bearish sentiment or hedging activity. The 47% spread signals divergent expectations across timeframes. Levels distributed around 3.33. Strong magnetic level at 3 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 3 | -0.33 (-10.04%) |
| Oct 17, 2025 | 3 | -0.33 (-10.04%) |
| Dec 19, 2025 | 3 | -0.33 (-10.04%) |
| Jan 16, 2026 | 3.5 | 0.17 (4.95%) |
| Mar 20, 2026 | 4 | 0.67 (19.94%) |
| Jan 15, 2027 | 2.5 | -0.83 (-25.04%) |